19Sep 2023
Prostate‐specific membrane antigen positron‐emission tomography for high‐risk prostate cancer patients

Prostate‐specific membrane antigen positron‐emission tomography for high‐risk prostate cancer patients

This study aims to assess the feasibility of using prostate-specific membrane antigen (PSMA) PET/CT as a single imaging modality to guide targeted biopsy and detect clinically significant prostate cancer (csPCa) in high-risk, biopsy-naïve men. The research finds that this PSMA-driven single imaging pathway can detect many csPCa cases, offering an alternative to diagnostic MRI scans.

  • #urology

Like

Save

Share